ARTICLE | Clinical News
Velcade bortezomib regulatory update
August 19, 2013 7:00 AM UTC
The European Commission approved a label extension for Velcade bortezomib from Johnson & Johnson to include induction treatment in combination with dexamethasone or with dexamethasone and thalidomide ...